May 152017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Bioverativ Inc. (NASDAQ:BIVV), a global biotechnology company focused on the discovery, development and commercialization of innovative therapies for hemophilia and other rare blood disorders, today announced the appointment of Geno J.=> Read more

Bioverativ adds Geno Germano to the Board as Independent Director

From:: Bioverativ adds Geno Germano to the Board as Independent Director

Sorry, the comment form is closed at this time.

%d bloggers like this: